"An observational study of alemtuzumab following fingolimod for multiple sclerosis." Neurology - Neuroimmunology Neuroinflammation
4.2
(2017):
e320.
Web. 02 June. 2023.
Advertisement
A peer-reviewed clinical and translational neurology open access journal
